FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3164289331> ?p ?o ?g. }

• W3164289331 endingPage "e11276" @default.
• W3164289331 startingPage "e11276" @default.
• W3164289331 abstract "Liver cancer is the second most common cause of cancer-induced deaths worldwide. Liver cirrhosis and cancer are a consequence of the abnormal angio-architecture formation of liver and formation of new blood vessels. This angiogenesis is driven by overexpression of hypoxia-inducible factor 1-alpha (Hif1- α ) and vascular endothelial growth factor (VEGF). Apart from this, protein kinase B (Akt) is also impaired in liver cancer. Despite the advancement in conventional treatments, liver cancer remains largely incurable. Nowadays, the use of naturally occurring anticancer agents particularly flavonoids is subject to more attention due to their enhanced physicochemical properties. Therefore, this study underlines the use of a natural anticancer agent taxifolin in the treatment of liver cancer using hepatocellular carcinoma cell line HepG2 and Huh7. The aim of our study is to devise a natural and efficient solution for the disease prevalent in Pakistan. The study involved the assessment of binding of ligand taxifolin using molecular docking. The binding of taxifolin with the proteins (Hif1- α , VEGF and Akt) was calculated by docking using Vina and Chimera. Further evaluation was performed by cell viability assay (MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) Assay), colony formation assay, cell migration assay, DNA ladder assay and flow cytometry. To see whether taxifolin directly affected expression levels, analysis of gene expression of Hif1- α , VEGF and Akt was performed using real-time polymerase chain reaction (qPCR) and western blotting. In silico docking experiments revealed that these proteins showed favorable docking scores with taxifolin. Treatment with taxifolin resulted in the inhibition of the liver cancer growth and migration, and induced apoptosis in HepG2 and Huh7 cell lines at an inhibitory concentration (IC50) value of 0.15 µM and 0.22 µM, respectively. The expression of HIF1- α , VEGF and Akt was significantly reduced in a dose- dependent manner. The inhibitory effect of taxifolin on hepatic cells suggested its chemopreventive and therapeutic potential. The studied compound taxifolin exhibited pronounced pro-apoptotic and hepatoprotective potential. Our study has confirmed the pro-apoptotic potential of taxifolin in liver cancer cell lines and will pave a way to the use of taxifolin as a chemotherapeutic agent after its further validation on the animal models and humans based epidemiological studies." @default.
• W3164289331 created "2021-06-07" @default.
• W3164289331 creator A5007901488 @default.
• W3164289331 creator A5021624457 @default.
• W3164289331 creator A5023579318 @default.
• W3164289331 creator A5050108742 @default.
• W3164289331 creator A5082692772 @default.
• W3164289331 date "2021-05-25" @default.
• W3164289331 modified "2023-10-17" @default.
• W3164289331 title "Evaluation of pro-apoptotic potential of taxifolin against liver cancer" @default.
• W3164289331 cites W1530007295 @default.
• W3164289331 cites W1600724420 @default.
• W3164289331 cites W1804809977 @default.
• W3164289331 cites W1965712234 @default.
• W3164289331 cites W1970060716 @default.
• W3164289331 cites W1977698530 @default.
• W3164289331 cites W1980150896 @default.
• W3164289331 cites W1984358846 @default.
• W3164289331 cites W1988969017 @default.
• W3164289331 cites W1990100055 @default.
• W3164289331 cites W1992905076 @default.
• W3164289331 cites W1995819508 @default.
• W3164289331 cites W2011502135 @default.
• W3164289331 cites W2025345760 @default.
• W3164289331 cites W2033205927 @default.
• W3164289331 cites W2044499234 @default.
• W3164289331 cites W2060697162 @default.
• W3164289331 cites W2062483322 @default.
• W3164289331 cites W2072884868 @default.
• W3164289331 cites W2080453950 @default.
• W3164289331 cites W2088629624 @default.
• W3164289331 cites W2095170921 @default.
• W3164289331 cites W2095931589 @default.
• W3164289331 cites W2098588686 @default.
• W3164289331 cites W2108666163 @default.
• W3164289331 cites W2108738678 @default.
• W3164289331 cites W2143385760 @default.
• W3164289331 cites W2171234651 @default.
• W3164289331 cites W2192333446 @default.
• W3164289331 cites W2336816986 @default.
• W3164289331 cites W2486336747 @default.
• W3164289331 cites W2490891607 @default.
• W3164289331 cites W2775010043 @default.
• W3164289331 cites W2781863422 @default.
• W3164289331 doi "https://doi.org/10.7717/peerj.11276" @default.
• W3164289331 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8162243" @default.
• W3164289331 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34113483" @default.
• W3164289331 hasPublicationYear "2021" @default.
• W3164289331 type Work @default.
• W3164289331 sameAs 3164289331 @default.
• W3164289331 citedByCount "10" @default.
• W3164289331 countsByYear W31642893312021 @default.
• W3164289331 countsByYear W31642893312022 @default.
• W3164289331 countsByYear W31642893312023 @default.
• W3164289331 crossrefType "journal-article" @default.
• W3164289331 hasAuthorship W3164289331A5007901488 @default.
• W3164289331 hasAuthorship W3164289331A5021624457 @default.
• W3164289331 hasAuthorship W3164289331A5023579318 @default.
• W3164289331 hasAuthorship W3164289331A5050108742 @default.
• W3164289331 hasAuthorship W3164289331A5082692772 @default.
• W3164289331 hasBestOaLocation W31642893311 @default.
• W3164289331 hasConcept C121608353 @default.
• W3164289331 hasConcept C153911025 @default.
• W3164289331 hasConcept C159110408 @default.
• W3164289331 hasConcept C167734588 @default.
• W3164289331 hasConcept C185592680 @default.
• W3164289331 hasConcept C190283241 @default.
• W3164289331 hasConcept C2776231280 @default.
• W3164289331 hasConcept C2777025900 @default.
• W3164289331 hasConcept C2778004101 @default.
• W3164289331 hasConcept C2778019345 @default.
• W3164289331 hasConcept C2778719679 @default.
• W3164289331 hasConcept C2780394083 @default.
• W3164289331 hasConcept C2780783641 @default.
• W3164289331 hasConcept C2781263971 @default.
• W3164289331 hasConcept C41685203 @default.
• W3164289331 hasConcept C502942594 @default.
• W3164289331 hasConcept C53227056 @default.
• W3164289331 hasConcept C54355233 @default.
• W3164289331 hasConcept C55493867 @default.
• W3164289331 hasConcept C71924100 @default.
• W3164289331 hasConcept C75217442 @default.
• W3164289331 hasConcept C86803240 @default.
• W3164289331 hasConcept C96232424 @default.
• W3164289331 hasConcept C98274493 @default.
• W3164289331 hasConceptScore W3164289331C121608353 @default.
• W3164289331 hasConceptScore W3164289331C153911025 @default.
• W3164289331 hasConceptScore W3164289331C159110408 @default.
• W3164289331 hasConceptScore W3164289331C167734588 @default.
• W3164289331 hasConceptScore W3164289331C185592680 @default.
• W3164289331 hasConceptScore W3164289331C190283241 @default.
• W3164289331 hasConceptScore W3164289331C2776231280 @default.
• W3164289331 hasConceptScore W3164289331C2777025900 @default.
• W3164289331 hasConceptScore W3164289331C2778004101 @default.
• W3164289331 hasConceptScore W3164289331C2778019345 @default.
• W3164289331 hasConceptScore W3164289331C2778719679 @default.
• W3164289331 hasConceptScore W3164289331C2780394083 @default.
• W3164289331 hasConceptScore W3164289331C2780783641 @default.

• next